Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM) - Role of Intramyocellular Lipid Content and Mitochondrial Dysfunction in Myocardial Insulin Resistance and Their Correction With Pioglitazone

NCT01588470 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at San Antonio as lead sponsor.

NCT NCT01588470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01588470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM) - Role of Intramyocellular Lipid Content and Mitochondrial Dysfunction in Myocardial Insulin Resistance and Their Correction With Pioglitazone
Lead sponsor
The University of Texas Health Science Center at San Antonio
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2006
Completion date
December 31, 2011
Enrollment
130 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, type 2 diabetes